Close

Analyst Ratings for Century Therapeutics (IPSC)

IPSC Rating Summary

IPSC Price Target Summary

* Over Last 12-Mos
  |   Expand Research on IPSC
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $14.50 (+295.1%) * Over Last 12-Mos
Rating Score: 7.8 / 10   Percentile Rank: 82%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
8/28/2023 JPMorgan Eric Joseph Downgrade Neutral
(Overweight)
5.00
(28.00)
2.40
(3.67)
52.92% Details
1/5/2023 EF Hutton Tony Butler New Coverage Buy
(N/A)
18.00
(N/A)
4.97
(3.67)
-26.16% Details
Like IPSC Ratings? Also take a look at MIRM, RPHM

IPSC Ratings News